We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Federal Circuit Says Cordis Likely To Prevail In Patent Case Vs. Boston Scientific

Law360 (June 1, 2004, 12:00 AM EDT) -- The Court of Appeals for the Federal Circuit in Washington, D.C. has confirmed that Cordis Corp. is likely to prevail at trial on the merits of claims that its core patent on balloon expandable stents is valid and infringed by Boston Scientific's Taxus Stent.

However, the court affirmed a lower court ruling denying Cordis Corporation a preliminary injunction barring sales of the Boston Scientific’s Taxus stent, citing a lack of irreparable harm from denial of the injunction.

"We are disappointed the Court of Appeals denied the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.